Literature DB >> 9259876

Structural and architectural changes during arterial development and the role of hemodynamics.

W E Stehbens1.   

Abstract

Hemodynamics is a major determinant in the anatomical and mural architectural development of the arterial tree. Arterial intimal proliferation commences in utero at specific anatomical sites often appearing eccentric in transverse section and precedes more diffuse concentric thickening. Regarded as an inherent structural component of the wall or an adaptive mural response to increasing hemodynamic stresses concomitant with growth, its occurrence in utero and in lower animals, though generally supportive of this view, ignores qualitative changes. Further doubt derives from the retrogressive destructive nature of structural changes in the arterial wall in the young, individual differences and their continued progression after birth and maturation. It is postulated that concomitantly with arterial development the associated degenerative changes are attributable to hemodynamically induced bioengineering fatigue caused by longitudinal stretching and circumferential distensile effects of the pulse waves and by lesser vibrations generated by flow at sites of predilection for compensatory intimal thickening. This intimal proliferation is the compensatory reparative response to loss of tensile strength of mural constituents and of the vessel wall as a whole.

Entities:  

Mesh:

Year:  1996        PMID: 9259876     DOI: 10.1159/000147889

Source DB:  PubMed          Journal:  Acta Anat (Basel)        ISSN: 0001-5180


  2 in total

1.  Possible role of NFkappaB in the embryonic vascular remodeling and the endothelial mesenchymal transition process.

Authors:  Enrique Arciniegas; Luz M Carrillo; Juan B De Sanctis; Daniel Candelle
Journal:  Cell Adh Migr       Date:  2008-01-23       Impact factor: 3.405

2.  Coronary artery dilatation and aortic outflow tract enlargement in children with unicommissural aortic valves.

Authors:  M J Faber; J S Zeiger; P J Spevak; J I Brenner; W J Ravekes
Journal:  Pediatr Cardiol       Date:  2005 Jul-Aug       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.